Submitted by Anonymous (not verified) on 24 September 2024 - 13:34
Human medicines European public assessment report (EPAR): Cegfila (previously Pegfilgrastim Mundipharma), pegfilgrastim, Date of authorisation: 19/12/2019, Revision: 8, Status: Authorised
Source: